GlassScriptPhysician profile
Menachem Wakslak
NPI 1902095854
$11,842.41
in general payments reported to CMS, 2019-2025
43 companies · $1,508 in 2025
The $1,508 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,696 · 2020: $3,517 · 2021: $1,157 · 2022: $1,440 · 2023: $1,576 · 2024: $947 · 2025: $1,508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,432 · Consulting Fee: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,431.70 |
| Consulting Fee | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $3,559.68 | 2019-2025 | Carto 3, Octaray Mapping Catheter, Qdot Micro Catheter |
| Abbott Laboratories | $1,971.98 | 2019-2025 | Gallant, Assurity, Aveir |
| Pfizer INC. | $927.66 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $782.24 | 2021-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $550.66 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $417.12 | 2019-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $384.43 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $276.16 | 2019-2024 | Accolade Sr, Resonate El Icd Vr, Emblem Mri S-Icd |
| Amgen INC. | $246.53 | 2019-2025 | Repatha |
| Medtronic, INC. | $210.05 | 2021-2025 | Selectsecure, Reveal Linq, Mycarelink |
| Astrazeneca Pharmaceuticals LP | $201.43 | 2019-2025 | Farxiga, Lokelma |
| Sanofi-Aventis U.S. LLC | $176.10 | 2021-2024 | |
| Kiniksa Pharmaceuticals, LTD. | $175.49 | 2021-2023 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $169.07 | 2021-2025 | Camzyos, Eliquis |
| Atricure, INC. | $166.17 | 2019-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Menachem Wakslak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.